Garvieacin Q, a novel class II bacteriocin from Lactococcus garvieae BCC 43578

Appl Environ Microbiol. 2012 Mar;78(5):1619-23. doi: 10.1128/AEM.06891-11. Epub 2011 Dec 30.

Abstract

Lactococcus garvieae BCC 43578 produces a novel class II bacteriocin, garvieacin Q (GarQ), 70 amino acids in length and containing a 20-amino-acid N-terminal leader peptide. It is cleaved at the Gly-Gly site to generate the mature GarQ (5,339 Da), which is especially inhibitory against Listeria monocytogenes ATCC 19115 and other L. garvieae strains.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteriocins / biosynthesis*
  • Bacteriocins / chemistry
  • Bacteriocins / genetics*
  • Bacteriocins / pharmacology
  • Lactococcus / genetics*
  • Lactococcus / metabolism*
  • Listeria monocytogenes / drug effects
  • Listeria monocytogenes / growth & development
  • Molecular Sequence Data
  • Molecular Weight
  • Sequence Analysis, DNA

Substances

  • Bacteriocins

Associated data

  • GENBANK/JN605800